Ansgar Lohse
Prof. Dr. med.
Ansgar W. Lohse
  • Klinikdirektor
  • Facharzt für Innere Medizin und Gastroenterologie


Hauptgebäude O10 , 2. Etage, Raumnummer
Deutsch (Muttersprache)







  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010

Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo
Allweiss L, Volz T, Giersch K, Kah J, Raffa G, Petersen J, Lohse A, Beninati C, Pollicino T, Urban S, Lütgehetmann M, Dandri M
GUT. 2017 [Epub ahead of print].

Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization
Dahlke C, Kasonta R, Lunemann S, Krähling V, Zinser M, Biedenkopf N, Fehling S, Ly M, Rechtien A, Stubbe H, Olearo F, Borregaard S, Jambrecina A, Stahl F, Strecker T, Eickmann M, Lütgehetmann M, Spohn M, Schmiedel S, Lohse A, Becker S, Addo M
EBioMedicine. 2017;19:107-118.

Increased frequency of CD39+ CD56 bright Natural Killer cells in HIV-1 infection correlates with immune activation and disease progression
Dierks P, Wroblewski R, Eberhard J, Martrus G, Degen O, Hertling S, Schmiedel S, Lunemann S, Hüfner A, Lohse A, Altfeld M, van Lunzen J, Schulze Zur Wiesch J
JAIDS-J ACQ IMM DEF. 2017;74(4):467-472.

Risk factors for excessively prolonged meropenem use in the intensive care settinga case-contol study
Katchanov J, Kreuels B, Maurer F, Wöstmann K, Jochum J, König C, Seoudy K, Rohde H, Lohse A, Wichmann D, Baehr M, Rothe C, Kluge S
BMC INFECT DIS. 2017;17(1):131.

Expert clinical management of autoimmune hepatitis in the real world
Liberal R, de Boer Y, Andrade R, Bouma G, Dalekos G, Floreani A, Gleeson D, Hirschfield G, Invernizzi P, Lenzi M, Lohse A, Macedo G, Milkiewicz P, Terziroli B, van Hoek B, Vierling J, Heneghan M
ALIMENT PHARM THER. 2017;45(5):723-732.

Efficacy and Limitations of Budesonide as a Second-line Treatment for Patients With Autoimmune Hepatitis
Peiseler M, Liebscher T, Sebode M, Zenouzi R, Hartl J, Ehlken H, Pannicke N, Weiler-Normann C, Lohse A, Schramm C
CLIN GASTROENTEROL H. 2017 [Epub ahead of print].

High clinical manifestation rate in an imported outbreak of hepatitis E genotype 1 infection in a German group of travellers returning from India
Pischke S, Schulze zur Wiesch J, Lütgehetmann M, Kreuels B, Lüth S, Kapaun P, Benten D, Schmiedel S, Sterneck M, Lohse A, Polywka S
ANN HEPATOL. 2017;16(1):57-62.

CD4+ T cells from patients with primary sclerosing cholangitis exhibit reduced apoptosis and down-regulation of proapoptotic Bim in peripheral blood
Schoknecht T, Schwinge D, Stein S, Weiler-Normann C, Sebode M, Mucha S, Otto B, Ellinghaus E, Stahl F, Franke A, Lohse A, Herkel J, Schramm C
J LEUKOCYTE BIOL. 2017;101(2):589-597.

Successful mTOR inhibitor therapy for a metastastic neuroendocrine tumour in a patient with a germline TSC2 mutation
Schrader J, Henes F, Perez D, Burdak-Rothkamm S, Stein A, Izbicki J, Lohse A
ANN ONCOL. 2017;28(4):904-905.

High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection
von Felden J, Heim D, Schulze K, Krech T, Ewald F, Nashan B, Lohse A, Wege H
BMC CANCER. 2017;17(1):60.

Viren überlisten: Globale Virusinfektionen werden beherrschbar - aber neue Gefahren drohen
Addo M, Lohse A
2016. Erkenntnis, Wissenschaft und Gesellschaft. Buchmüller W, Jakobeit C (Hrsg.). 1. Aufl. Springer-Verlag GmbH and Co. KG, 101-118.

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
Agnandji S, Huttner A, Zinser M, Njuguna P, Dahlke C, Fernandes J, Yerly S, Dayer J, Kraehling V, Kasonta R, Adegnika A, Altfeld M, Auderset F, Bache E, Biedenkopf N, Borregaard S, Brosnahan J, Burrow R, Combescure C, Desmeules J, Eickmann M, Fehling S, Finckh A, Goncalves A, Grobusch M, Hooper J, Jambrecina A, Kabwende A, Kaya G, Kimani D, Lell B, Lemaître B, Lohse A, Massinga-Loembe M, Matthey A, Mordmüller B, Nolting A, Ogwang C, Ramharter M, Schmidt-Chanasit J, Schmiedel S, Silvera P, Stahl F, Staines H, Strecker T, Stubbe H, Tsofa B, Zaki S, Fast P, Moorthy V, Kaiser L, Krishna S, Becker S, Kieny M, Bejon P, Kremsner P, Addo M, Siegrist C
NEW ENGL J MED. 2016;374(17):1647-60.

Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation
Allweiss L, Gass S, Giersch K, Groth A, Kah J, Volz T, Rapp G, Schöbel A, Lohse A, Polywka S, Pischke S, Herker E, Dandri-Petersen M, Lütgehetmann M
J HEPATOL. 2016;64(5):1033-1040.

Determinants and frequency of irritable bowel syndrome in a German sample
Althaus A, Broicher W, Wittkamp P, Andresen V, Lohse A, Löwe B
Z GASTROENTEROL. 2016;54(3):217-225.

Post-infectious irritable bowel syndrome (PI-IBS) after infection with Shiga-like toxin-producing Escherichia coli (STEC) O104:H4: A cohort study with prospective follow-up
Andresen V, Löwe B, Broicher W, Riegel B, Zimmermann-Fraedrich K, von Wulffen M, Gappmayer K, Wegscheider K, Treszl A, Rose M, Layer P, Lohse A
UNITED EUR GASTROENT. 2016;4(1):121-31.

Infections complicating severe alcoholic Hepatitis: Enterococcus species represent the most frequently identified pathogen
Beisel C, Blessin U, Schulze Zur Wiesch J, Wehmeyer M, Lohse A, Benten D, Kluwe J
SCAND J GASTROENTERO. 2016;51(7):807-13.

Two Cases of Hepatosplenic T-Cell Lymphoma in Adolescents Treated for Autoimmune Hepatitis
Brinkert F, Arrenberg P, Krech T, Grabhorn E, Lohse A, Schramm C
PEDIATRICS. 2016;138(3):e20154245.

Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation
Ciesek S, Proske V, Otto B, Pischke S, Costa R, Lütgehetmann M, Polywka S, Klempnauer J, Nashan B, Manns M, von Hahn T, Lohse A, Wedemeyer H, Mix H, Sterneck M
TRANSPL INFECT DIS. 2016;18(3):326-32.

Systemic inflammation in decompensated cirrhosis Characterization and role in acute-on-chronic liver failure
Clària J, Stauber R, Coenraad M, Moreau R, Jalan R, Pavesi M, Amorós À, Titos E, Alcaraz-Quiles J, Oettl K, Morales-Ruiz M, Angeli P, Domenicali M, Alessandria C, Gerbes A, Wendon J, Nevens F, Trebicka J, Laleman W, Saliba F, Welzel T, Albillos A, Gustot T, Benten D, Durand F, Ginès P, Bernardi M, Arroyo V, , Lohse A, Wege H
HEPATOLOGY. 2016;64(4):1249-64.

Reduced CD161(+) MAIT cell frequencies in HCV and HIV/HCV co-infection: Is the liver the heart of the matter?
Eberhard J, Kummer S, Hartjen P, Hüfner A, Diedrich T, Degen O, Lohse A, Lunzen J, Schulze Zur Wiesch J
J HEPATOL. 2016;65(6):1261-1263.

Spleen size for the prediction of clinical outcome in patients with primary sclerosing cholangitis
Ehlken H, Wroblewski R, Corpechot C, Arrivé L, Lezius S, Hartl J, Denzer U, Lohse A, Chazouilleres O, Schramm C
GUT. 2016;65(7):1230-2.

Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis
Ehlken H, Wroblewski R, Corpechot C, Arrivé L, Rieger T, Hartl J, Lezius S, Hübener P, Schulze K, Zenouzi R, Sebode M, Peiseler M, Denzer U, Quaas A, Weiler-Normann C, Lohse A, Chazouilleres O, Schramm C
PLOS ONE. 2016;11(10):e0164224.

Saccharomyces boulardii to Prevent Antibiotic-Associated Diarrhea: A Randomized, Double-Masked, Placebo-Controlled Trial
Ehrhardt S, Guo N, Hinz R, Schoppen S, May J, Reiser M, Schroeder M, Schmiedel S, Keuchel M, Reisinger E, Langeheinecke A, de Weerth A, Schuchmann M, Schaberg T, Ligges S, Eveslage M, Hagen R, Burchard G, Lohse A, , Kreuels B
Open Forum Infect Dis. 2016;3(1):ofw011.

Fäkaler Mikrobiota-Transfer bei rezidivierenden Clostridium-difficile-Infektionen
Hagel S, Fischer A, Ehlermann P, Frank T, Tueffers K, Sturm A, Link A, Demir M, Siebenhaar A, Storr M, Glueck T, Siegel E, Solbach P, Goeser F, Koelbel C, Lohse A, Luebbert C, Kandzi U, Maier M, Schuerle S, Lerch M, Tacke D, Cornely O, Stallmach A, Vehreschild M, German Clinical Microbiome Study Group (GCMSG) o
DTSCH ARZTEBL INT. 2016;113(35-36):583-9.

Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis
Hartl J, Denzer U, Ehlken H, Zenouzi R, Peiseler M, Sebode M, Hübener S, Pannicke N, Weiler-Normann C, Quaas A, Lohse A, Schramm C
J HEPATOL. 2016;65(4):769-75.

Hepatitis E Seroprevalence in Europe: A Meta-Analysis
Hartl J, Otto B, Madden R, Webb G, Woolson K, Kriston L, Vettorazzi E, Lohse A, Dalton H, Pischke S
VIRUSES. 2016;8(8):E211.

Constitutive gp130 activation rapidly accelerates the transformation of human hepatocytes via an impaired oxidative stress response
Heim D, Gil-Ibanez I, Herden J, Parplys A, Borgmann K, Schmidt-Arras D, Lohse A, Rose-John S, Wege H
ONCOTARGET. 2016;7(34):55639-55648.

Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance
Hübener S, Oo Y, Than N, Hübener P, Weiler-Normann C, Lohse A, Schramm C
CLIN GASTROENTEROL H. 2016;14(3):445-453.

Reply to: Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance.
Hübener S, Than N, Oo Y, Lohse A, Schramm C
CLIN GASTROENTEROL H. 2016;14(7):1063-4.

Heme oxygenase-1 polymorphisms can affect HCV replication and treatment responses with different efficacy in humanized mice
Kah J, Volz T, Lütgehetmann M, Groth A, Lohse A, Tiegs G, Sass G, Dandri-Petersen M
LIVER INT. 2016 [Epub ahead of print].

Diffusion-weighted MRI for detection of hepatic osteodystrophy in primary sclerosing cholangitis a comparison study with dual-energy X-ray absorptiometry
Keller S, Ittrich H, Schramm C, Lohse A, Amling M, Adam G, Yamamura J
JPN J RADIOL. 2016;34(10):677-683.

Acute Ebola virus disease patient treatment and health-related quality of life in health care professionals: A controlled study
Lehmann M, Brünahl C, Addo M, Becker S, Schmiedel S, Lohse A, Schramm C, Löwe B
J PSYCHOSOM RES. 2016;83:69-74.

Reply to "Further considerations in autoimmune hepatitis"
Lohse A, Chazouilleres O, Dalekos G, Drenth J, Heneghan M, Hofer H, Lammert F, Lenzi M
J HEPATOL. 2016;64(6):1458-9.

The Development of Irritable Bowel Syndrome: A Prospective Community-Based Cohort Study
Löwe B, Lohse A, Andresen V, Vettorazzi E, Rose M, Broicher W
AM J GASTROENTEROL. 2016;111(9):1320-9.

A pathogenic role for T cell-derived IL-22BP in inflammatory bowel disease
Pelczar P, Witkowski M, Perez L, Kempski J, Hammel A, Brockmann L, Kleinschmidt D, Wende S, Haueis C, Bedke T, Krasemann S, Steurer S, Booth C, Busch C, König A, Rauch U, Benten D, Izbicki J, Rösch T, Lohse A, Strowig T, Gagliani N, Flavell R, Huber S
SCIENCE. 2016;354(6310):358-362.

Course of hepatitis C virus (HCV) RNA and HCV core antigen testing are predictors for reaching sustained virologic response in liver transplant recipients undergoing sofosbuvir treatment in a real-life setting
Pischke S, Polywka S, Proske V, Lang M, Jordan S, Nashan B, Lohse A, Sterneck M
TRANSPL INFECT DIS. 2016;18:141-145.

Blood-borne Hepatitis E Virus Transmission: A Relevant Risk for Immunosuppressed Patients
Pischke S, Hiller J, Lütgehetmann M, Polywka S, Rybczynski M, Ayuketang F, Lohse A
CLIN INFECT DIS. 2016;63(4):569-570.

Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process
Ponsioen C, Chapman R, Chazouillères O, Hirschfield G, Karlsen T, Lohse A, Pinzani M, Schrumpf E, Trauner M, Gores G
HEPATOLOGY. 2016;63(4):1357-67.

Multiple Abszesse nach Südamerikakreuzfahrt
Reynolds K, Schofer N, Zengin E, Lohse A, Faiss S, Schmiedel S
INTERNIST. 2016;57(3):284-8.

Unique human immune signature of Ebola virus disease in Guinea
Ruibal P, Oestereich L, Lüdtke A, Becker-Ziaja B, Wozniak D, Kerber R, Korva M, Cabeza-Cabrerizo M, Bore J, Koundouno F, Duraffour S, Weller R, Thorenz A, Cimini E, Viola D, Agrati C, Repits J, Afrough B, Cowley L, Ngabo D, Hinzmann J, Mertens M, Vitoriano I, Logue C, Boettcher J, Pallasch E, Sachse A, Bah A, Nitzsche K, Kuisma E, Michel J, Holm T, Zekeng E, García-Dorival I, Wölfel R, Stoecker K, Fleischmann E, Strecker T, Di Caro A, Avšič-Županc T, Kurth A, Meschi S, Mély S, Newman E, Bocquin A, Kis Z, Kelterbaum A, Molkenthin P, Carletti F, Portmann J, Wolff S, Castilletti C, Schudt G, Fizet A, Ottowell L, Herker E, Jacobs T, Kretschmer B, Severi E, Ouedraogo N, Lago M, Negredo A, Franco L, Anda P, Schmiedel S, Kreuels B, Wichmann D, Addo M, Lohse A, De Clerck H, Nanclares C, Jonckheere S, Van Herp M, Sprecher A, Xiaojiang G, Carrington M, Miranda O, Castro C, Gabriel M, Drury P, Formenty P, Diallo B, Koivogui L, Magassouba N, Carroll M, Günther S, Muñoz-Fontela C
NATURE. 2016;533(7601):100-4.

Medizinische Versorgung von Flüchtlingen: Eine Fallserie des Universitätsklinikums Hamburg-Eppendorf
Sothmann P, Schmedt auf der Günne N, Addo M, Lohse A, Schmiedel S
DEUT MED WOCHENSCHR. 2016;141(1):34-37.

Medizinische Versorgung von Flüchtlingen – Eine Fallserie des Universitätsklinikums Hamburg-Eppendorf
Sothmann P, Schmedt auf der Günne N, Roggelin L, Kreuels B, Rothe C, Addo M, Lohse A, Schulze zur Wiesch J, Schmiedel S
Flug-Tropen-Reisemedizin. 2016;23(1):45-49.

Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy
Than N, Wiegard C, Weiler-Normann C, Füssel K, Mann J, Hodson J, Hirschfield G, Lohse A, Adams D, Schramm C, Oo Y
SCAND J GASTROENTERO. 2016;51(3):329-336.

Nonalcoholic fatty liver disease is associated with excessive calorie intake rather than a distinctive dietary pattern
Wehmeyer M, Zyriax B, Jagemann B, Roth E, Windler E, Schulze Zur Wiesch J, Lohse A, Kluwe J
MEDICINE. 2016;95(23):e3887.

Variant Syndromes of Autoimmune Liver Diseases: Classification, Diagnosis and Management
Weiler-Normann C, Lohse A
DIGEST DIS. 2016;34(4):334-9.

Nonalcoholic Fatty Liver Disease in Patients with Autoimmune Hepatitis: Further Reason for Teeth GNASHing?
Weiler-Normann C, Lohse A
DIGEST DIS SCI. 2016;61(9):2462 - 64.

Opposing role of tumor necrosis factor receptor 1 signaling in T cell-mediated hepatitis and bacterial infection in mice
Wroblewski R, Armaka M, Kondylis V, Pasparakis M, Walczak H, Mittrücker H, Schramm C, Lohse A, Kollias G, Ehlken H
HEPATOLOGY. 2016;64(2):508-521.

No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis
Zenouzi R, Weismüller T, Jørgensen K, Bubenheim M, Lenzen H, Hübener P, Schulze K, Weiler-Normann C, Sebode M, Ehlken H, Pannicke N, Hartl J, Peiseler M, Hübener S, Karlsen T, Boberg K, Manns M, Lohse A, Schramm C
CLIN GASTROENTEROL H. 2016;14(12):1806-1812.

Determination of ethyl glucuronide in hair for detection of alcohol consumption in patients after livertransplantation.
Andresen-Streichert H, von Rothkirch G, Vettorazzi E, Müller A, Lohse A, Frederking D, Seegers B, Nashan B, Sterneck M
THER DRUG MONIT. 2015;37(4):539-545.

Geschlechtsunterschiede bei Infektionserkrankungen
Beisel C, Lunzen J, Lohse A, Addo M, Altfeld M
DEUT MED WOCHENSCHR. 2015;140(18):1385-90.

Combined glucocorticoid and antiviral therapy of hepatitis B virus-related liver failure
Bockmann J, Dandri-Petersen M, Lüth S, Pannicke N, Lohse A, Dandri-Petersen M
WORLD J GASTROENTERO. 2015;21(7):2214-9.

Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice
Carambia A, Freund B, Schwinge D, Bruns O, Salmen S, Ittrich H, Reimer R, Heine M, Huber S, Waurisch C, Eychmüller A, Wraith D, Korn T, Nielsen P, Weller H, Schramm C, Lüth S, Lohse A, Heeren J, Herkel J
J HEPATOL. 2015;62(6):1349-1356.

Unmet clinical need in autoimmune liver diseases
Dyson J, Webb G, Hirschfield G, Lohse A, Beuers U, Lindor K, Jones D
J HEPATOL. 2015;62(1):208-18.

Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting
Galante A, Pischke S, Polywka S, Lütgehetmann M, Suneetha P, Gisa A, Hiller J, Dienes H, Nashan B, Lohse A, Sterneck M
TRANSPL INFECT DIS. 2015;17(4):617-22.

Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection
Giersch K, Allweiss L, Volz T, Helbig M, Bierwolf J, Lohse A, Pollok J, Petersen J, Dandri-Petersen M, Lütgehetmann M
J HEPATOL. 2015;63(2):346-53.

Ökonomische Auswirkungen einer Clostridium-difficile-Enterokoloitis in deutschen Krankenhäusern auf der Basis von DRG-Kostendaten
Grube R, Heinlein W, Scheffer H, Rathmayer M, Schepp W, Lohse A, Stallmach A, Wilke M, Lerch M
Z GASTROENTEROL. 2015;53(5):391-397.

S2k-Leitlinie Gastrointestinale Infektionen und Morbus Whipple
Hagel S, Epple H, Feurle G, Kern W, Lynen-Jansen P, Malfertheiner P, Marth T, Meyer E, Mielke M, Moos V, von Müller L, Nattermann J, Nothacker M, Pox C, Reisinger E, Salzberger B, Salzer H, Weber M, Weinke T, Suerbaum S, Lohse A, Stallmach A
Z GASTROENTEROL. 2015;53(05):418-459.

Comparison of autochthonous and imported cases of hepatitis A or hepatitis E
Hartl J, Kreuels B, Polywka S, Addo M, Lütgehetmann M, Dandri-Petersen M, Dammermann W, Sterneck M, Lohse A, Pischke S
Z GASTROENTEROL. 2015;53(7):639-643.

Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis
Hartl J, Ehlken H, Weiler-Normann C, Sebode M, Kreuels B, Pannicke N, Zenouzi R, Glaubke C, Lohse A, Schramm C
J HEPATOL. 2015;62(3):642-6.

Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifies RIPK4 as novel tumor suppressor in human hepatocarcinogenesis
Heim D, Cornils K, Schulze K, Fehse B, Lohse A, Brümmendorf T, Wege H
ONCOGENE. 2015;34(3):385-393.

Ebola and psychological stress of health care professionals
Lehmann M, Brünahl C, Löwe B, Addo M, Schmiedel S, Lohse A, Schramm C
EMERG INFECT DIS. 2015;21(5):913-914.

Psychosoziale Belastungen von Ärzten und Pflegepersonal bei der Behandlung eines mit dem Ebola-Virus infizierten Patienten am Universitätsklinikum Hamburg Eppendorf im September 2014
Lehmann M, Brünahl C, Löwe B, Addo M, Schramm C, Schmiedel S, Lohse A

Diagnostic Criteria for Autoimmune Hepatitis: Scores and More
Lohse A
DIGEST DIS. 2015;33( Suppl. 2):47-52.

Autoimmune Hepatitis - Update 2015
Manns M, Lohse A, Vergani D
J HEPATOL. 2015;62(1 Suppl):S100-S111.

Neue S2k-Leitlinie "Gastrointestinale Infektionen und Morbus Whipple"
Manthey C, Hagel S, Lohse A, Stallmach A
Ärzteblatt Thüringen. 2015;26(12):696-700.

Neue Leitlinie: Wann eine Erregerdiagnostik sinnvoll ist.
Manthey C, Hagel S, Stallmach A, Lohse A
Hamb Arztebl. 2015;69(11):24-25.

Definition of Chronic Hepatitis E after Liver Transplantation Conforms to Convention
Meisner S, Polywka S, Memmler M, Nashan B, Lohse A, Sterneck M, Pischke S
AM J TRANSPLANT. 2015;15(11):3011-3012.

Quality of life one year post-Shiga Toxin-producing Eschericia coli O104 infection - A prospective cohort study
Riegel B, Broicher W, Wegscheider K, Andresen V, Brähler E, Lohse A, Löwe B
NEUROGASTROENT MOTIL. 2015;27(3):370-378.

Primary Biliary Cirrhosis: Time to Replace a Misnomer
Schramm C, Wahl I, Lohse A
HEPATOLOGY. 2015;61(4):1435.

Criteria Used in Clinical Practice to Guide Immunosuppressive Treatment in Patients with PrimarCortico-Cerebellar Structural Connectivity Is Related to Residual Motor Output in Chronic Strokey Sclerosing Cholangitis
Schulze K, Weismüller T, Bubenheim M, Hübener P, Zenouzi R, Lenzen H, Rupp C, Gotthardt D, de Leuw P, Teufel A, Zimmer V, Reiter F, Rust C, Tharun L, Quaas A, Weidemann S, Lammert F, Sarrazin C, Manns M, Lohse A, Schramm C
PLOS ONE. 2015;10(10):Art. e0140525.

Testosterone Suppresses Hepatic Inflammation by the Downregulation of IL-17, CXCL-9, and CXCL-10 in a Mouse Model of Experimental Acute Cholangitis
Schwinge D, Carambia A, Quaas A, Krech T, Wegscheid C, Tiegs G, Prinz I, Lohse A, Herkel J, Schramm C
J IMMUNOL. 2015;194(6):2522-30.

Phenotypic alterations of regulatory T cells in autoimmune hepatitis: causal or associated with treatment and remission?
Sebode M, Peiseler M, Weiler-Normann C, Schramm C, Lohse A, Herkel J
HEPATOLOGY. 2015;61(2):736-37.

Diagnostik und Therapie infektiöser Durchfallerkrankungen Was ist gesichert?
Stallmach A, Hagel S, Lohse A
INTERNIST. 2015;56:1353-1360.

Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in Treatment-naive patients with chronic Hepatitis C Virus infection and advanced liver fibrosis or cirrhosis.
Stefan Z, Soriano V, Asselah T, Gane E, Bronowicki J, Angus P, Lohse A, Stickel F, Mülhaupt B, Roberts S, Schuchmann M, Manns M, Boulière M, Buti M, Stern J, Gallivan J, Voss F, Sabo J, Böcher W, Mensa F
J ANTIMICROB CHEMOTH. 2015;59(2):1282-1291.

Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial
Stein A, Arnold D, Bridgewater J, Goldstein D, Jensen L, Klümpen H, Lohse A, Nashan B, Primrose J, Schrum S, Shannon J, Vettorazzi E, Wege H
BMC CANCER. 2015;15:Art. 564.

Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma: A multicenter prospective phase II study
Wagner A, Denzer U, Neureiter D, Kiesslich T, Puespoeck A, Rauws E, Emmanuel K, Degenhardt N, Frick U, Beuers U, Lohse A, Berr F, Wolkersdörfer G
HEPATOLOGY. 2015;62(5):1456-65.

Primary biliary "cirrhosis" time to replace a misnomer
Wahl I, Feige A, Löwe B, Weiler-Normann C, Rose M, Lohse A, Schramm C
HEPATOLOGY. 2015;61(3):1091.

High Rate of Cardiac Abnormalities in a Postmortem Analysis of Patients Suffering From Liver Cirrhosis
Wehmeyer M, Heuer A, Benten D, Püschel K, Sydow K, Lohse A, Lüth S
J CLIN GASTROENTEROL. 2015;49(10):866-872.

Efficacy and safety of sofosbuvir-based triple therapy in hepatitis C genotype 4 infection.
Wehmeyer M, Jordan S, Lüth S, Hartl J, Stoehr A, Eißing C, Lohse A, Petersen J, Buggisch P, Schulze zur Wiesch J
DIGEST LIVER DIS. 2015;47(9):811-814.

Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration
Allweiss L, Volz T, Lütgehetmann M, Giersch K, Bornscheuer T, Lohse A, Petersen J, Ma H, Klumpp K, Fletcher S, Dandri M
J HEPATOL. 2014;60(3):500-7.

Association of autoimmune hepatitis and systemic lupus erythematodes: a case series and review of the literature
Beisel C, Weiler-Normann C, Teufel A, Lohse A
WORLD J GASTROENTERO. 2014;20(35):12662-12667.

TGF-β-dependent induction of CD4⁺CD25⁺Foxp3⁺ Tregs by liver sinusoidal endothelial cells
Carambia A, Freund B, Schwinge D, Heine M, Laschtowitz A, Huber S, Wraith D, Korn T, Schramm C, Lohse A, Heeren J, Herkel J
J HEPATOL. 2014;61(3):594-9.

Genome-wide association study identifies variants associated with autoimmune hepatitis type 1
de Boer Y, van Gerven N, Zwiers A, Verwer B, van Hoek B, van Erpecum K, Beuers U, van Buuren H, Drenth J, den Ouden J, Verdonk R, Koek G, Brouwer J, Guichelaar M, Vrolijk J, Kraal G, Mulder C, van Nieuwkerk C, Fischer J, Berg T, Stickel F, Sarrazin C, Schramm C, Lohse A, Weiler-Normann C, Lerch M, Nauck M, Völzke H, Homuth G, Bloemena E, Verspaget H, Kumar V, Zhernakova A, Wijmenga C, Franke L, Bouma G
GASTROENTEROLOGY. 2014;147(2):443-452.

Transient elastography in primary sclerosing cholangitis-the value as a prognostic factor and limitations
Ehlken H, Lohse A, Schramm C
GASTROENTEROLOGY. 2014;147(2):542-543.

Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection
Giersch K, Helbig M, Volz T, Allweiss L, Mancke L, Lohse A, Polywka S, Pollok J, Petersen J, Taylor J, Dandri M, Lütgehetmann M
J HEPATOL. 2014;60(3):538-44.

Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure
Jalan R, Saliba F, Pavesi M, Amoros A, Moreau R, Ginès P, Levesque E, Durand F, Angeli P, Caraceni P, Hopf C, Alessandria C, Rodriguez E, Solis-Muñoz P, Laleman W, Trebicka J, Zeuzem S, Gustot T, Mookerjee R, Elkrief L, Soriano G, Cordoba J, Morando F, Gerbes A, Agarwal B, Samuel D, Bernardi M, Arroyo V, , Wege H, Benten D, Lohse A
J HEPATOL. 2014;61(5):1038-1047.

A case of severe Ebola virus infection complicated by gram-negative septicemia
Kreuels B, Wichmann D, Emmerich P, Schmidt-Chanasit J, Heer G, Kluge S, Sow A, Renné T, Günther S, Lohse A, Addo M, Schmiedel S
NEW ENGL J MED. 2014;371(25):2394-401.

Psychological Outcome, Fatigue, and Quality of Life After Infection With Shiga Toxin-Producing Escherichia coli O104
Löwe B, Andresen V, Zimmermann-Fraedrich K, Gappmayer K, Wegscheider K, Treszl A, Riegel B, Rose M, Lohse A, Broicher W

Prevention of hemolytic uremic syndrome with daily bowel lavage in patients with Shiga toxin-producing enterohemorrhagic Escherichia coli O104:H4 infection
Lüth S, Fründt T, Rösch T, Schlee C, Lohse A
JAMA INTERN MED. 2014;174(6):1003-5.

Entwicklung infektiöser Durchfallerkrankungen zwischen den Jahren 2000 und 2012
Lynen Jansen P, Stallmach A, Lohse A, Lerch M
Z GASTROENTEROL. 2014;52(6):549-57.

Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme
Moehler M, Maderer A, Schimanski C, Kanzler S, Denzer U, Kolligs F, Ebert M, Distelrath A, Geissler M, Trojan J, Schütz M, Berie L, Sauvigny C, Lammert F, Lohse A, Dollinger M, Lindig U, Duerr E, Lubomierski N, Zimmermann S, Wachtlin D, Kaiser A, Schadmand-Fischer S, Galle P, Woerns M, , Denzer U
EUR J CANCER. 2014;50(18):3125-35.

Analysis of the power of common diagnostic tools in the management of acute pancreatitis
Nistal M, Zoltani M, Lohse A, Di Daniele N, Tesauro M, Pace A
GASTROENT RES PRACT. 2014;2014:438697.

Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism
Oehler N, Volz T, Bhadra O, Kah J, Allweiss L, Giersch K, Bierwolf J, Riecken K, Pollok J, Lohse A, Fehse B, Petersen J, Urban S, Lütgehetmann M, Heeren J, Dandri M

Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection
Roeder C, Jordan S, Schulze Zur Wiesch J, Pfeiffer-Vornkahl H, Hueppe D, Mauss S, Zehnter E, Stoll S, Alshuth U, Lohse A, Lüth S
WORLD J GASTROENTERO. 2014;20(31):10984-10993.

Autoimmune hepatitis on the rise
Schramm C, Lohse A
J HEPATOL. 2014;60(3):478-479.

Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis
Schramm C, Wahl I, Weiler-Normann C, Voigt K, Wiegard C, Glaubke C, Brähler E, Löwe B, Lohse A, Rose M
J HEPATOL. 2014;60(3):618-624.

Reduced FOXP3(+) regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms
Sebode M, Peiseler M, Franke B, Schwinge D, Schoknecht T, Wortmann F, Quaas A, Petersen B, Ellinghaus E, Baron U, Olek S, Wiegard C, Weiler-Normann C, Lohse A, Herkel J, Schramm C
J HEPATOL. 2014;60(5):1010-6.

New foe treated with old guns - supportive role of steroids in the treatment of acute severe hepatitis E
Sebode M, Pischke S, Lütgehetmann M, Polywka S, Quaas A, Lohse A, Wege H
BMC GASTROENTEROL. 2014;14(191):.

Future perspective: immunomodulatory therapy for autoimmune hepatitis
Sebode M, Lohse A
DIGEST DIS. 2014;32(5):502-506.

CD4+ T-cell help is required for effective CD8+ T cell-mediated resolution of acute viral hepatitis in mice
Trautmann T, Kozik J, Carambia A, Richter K, Lischke T, Schwinge D, Mittrücker H, Lohse A, Oxenius A, Wiegard C, Herkel J
PLOS ONE. 2014;9(1):e86348.

Safety and efficacy of protease inhibitor based combination therapy in a single-center "real-life" cohort of 110 patients with chronic hepatitis C genotype 1 infection
Wehmeyer M, Eißing F, Jordan S, Röder C, Hennigs A, Degen O, Hüfner A, Hertling S, Schmiedel S, Sterneck M, Lunzen J, Lohse A, Schulze Zur Wiesch J, Lüth S

Prediction of spontaneous bacterial peritonitis in cirrhotic ascites by a simple scoring system
Wehmeyer M, Krohm S, Kastein F, Lohse A, Lüth S
SCAND J GASTROENTERO. 2014;49(5):595-603.

Reply to: "Anti-TNF-induced autoimmune hepatitis"
Weiler-Normann C, Herkel J, Schramm C, Lohse A
J HEPATOL. 2014;61(1):170-171.

Matrix Conditions and KLF2-Dependent Induction of Heme Oxygenase-1 Modulate Inhibition of HCV Replication by Fluvastatin
Wüstenberg A, Kah J, Singethan K, Sirma H, Keller A, Perez Rosal S, Schrader J, Loscher C, Volz T, Bartenschlager R, Lohmann V, Protzer U, Dandri M, Lohse A, Tiegs G, Sass G
PLOS ONE. 2014;9(5):e96533.

Autoimmune Hepatitis - aktuelle Entwicklungen einer zunehmenden Erkrankung
Zenouzi R, Hartl J, Lohse A
DEUT MED WOCHENSCHR. 2014;139(40):2020-2.

Low Risk of Hepatocellular Carcinoma in Patients With Primary Sclerosing Cholangitis With Cirrhosis
Zenouzi R, Weismüller T, Hübener P, Schulze K, Bubenheim M, Pannicke N, Weiler-Normann C, Lenzen H, Manns M, Lohse A, Schramm C

Long-term outcome in PSC/AIH "overlap syndrome": does immunosuppression also treat the PSC component?
Zenouzi R, Lohse A
J HEPATOL. 2014;61(5):1189-1191.

Inhibition of inflammatory CD4 T cell activity by murine liver sinusoidal endothelial cells
Carambia A, Frenzel C, Bruns O, Schwinge D, Reimer R, Hohenberg H, Huber S, Tiegs G, Schramm C, Lohse A, Herkel J
J HEPATOL. 2013;58(1):112-8.

Increased expression of complement regulators CD55 and CD59 on peripheral blood cells in patients with EAHEC O104:H4 infection
Dammermann W, Schipper P, Ullrich S, Zimmermann-Fraedrich K, Schulze Zur Wiesch J, Fründt T, Tiegs G, Lohse A, Lüth S
PLOS ONE. 2013;8(9):e74880.

Toll like receptor 2 agonists lipoteichoic acid and peptidoglycan are able to enhance antigen specific IFNγ release in whole blood during recall antigen responses
Dammermann W, Wollenberg L, Bentzien F, Lohse A, Lüth S
Journal of immunological methods. 2013;396(1-2):107-15.

EHEC-O104:H4-Ausbruch im Sommer 2011
Fründt T, Höpker W, Hagel C, Sperhake J, Isenberg A, Lüth S, Lohse A, Sauter G, Glatzel M, Püschel K
RECHTSMEDIZIN. 2013;23:374–382 .

44-jährige Patientin mit hereditärem nichtpolypösem Kolonkarzinom
Holzhüter J, Rösch T, Block A, Lohse A, Lüth S
INTERNIST. 2013;54(3):353-8.

A 44-year-old woman with hereditary nonpolyposis colon carcinoma: screening examinations for non-colonic tumors.
Holzhüter J, Rösch T, Block A, Lohse A, Lüth S
INTERNIST. 2013;54:353-358.

Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis
Katt J, Schwinge D, Schoknecht T, Quaas A, Sobottka I, Burandt E, Becker C, Neurath M, Lohse A, Herkel J, Schramm C
HEPATOLOGY. 2013;58(3):1084-93.

Antiviral effect, safety, and pharmacokinetics of five-day oral administration of Deleobuvir (BI 207127), an investigational hepatitis C virus RNA polymerase inhibitor, in patients with chronic hepatitis C
Larrey D, Lohse A, Trepo C, Bronowicki J, Arastéh K, Bourlière M, Calleja J, Stern J, Nehmiz G, Abdallah N, Berger K, Marquis M, Steffgen J, Kukolj G
Antimicrobial agents and chemotherapy. 2013;57(10):4727-35.

Not all PBC is the same!
Lohse A, Weiler-Normann C
GASTROENTEROLOGY. 2013;144(3):494-7.

Komorbidität rheumatischer und hepatologischer Erkrankungen
Mayet W, Lohse A
Z RHEUMATOL. 2013;72(6):547-54.

Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis
Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, Gustot T, Saliba F, Domenicali M, Gerbes A, Wendon J, Alessandria C, Laleman W, Zeuzem S, Trebicka J, Bernardi M, Arroyo V, , Lohse A, Wege H, Benten D
GASTROENTEROLOGY. 2013;144(7):1426-37, 1437.e1-9.

Hepatopulmonary syndrome caused by sarcoidosis of the liver treated with transjugular intrahepatic portosystemic shunt.
Nistal M, Pace A, Klose H, Benten D, Lohse A
THORAX. 2013;68(9):889-890.

Antibiotika-Forschung: Probleme und Perspektiven
Reinitzer H, Lohse A, Hacker J

Infiltration of peritumoural but tumour-free parenchyma with IgG4-positive plasma cells in hilar cholangiocarcinoma and pancreatic adenocarcinoma
Resheq Y, Quaas A, von Renteln D, Schramm C, Lohse A, Lüth S
DIGEST LIVER DIS. 2013;45(10):859-65.

Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma
Schulze K, Gasch C, Staufer K, Nashan B, Lohse A, Pantel K, Riethdorf S, Wege H
INT J CANCER. 2013;133(9):2165-71.

Inflammatorische Erkrankungen mit Leber- und Gelenkbeteiligung. Eine differenzialdiagnostische Herausforderung
Sebode M, Schramm C, Lohse A
INTERNIST. 2013;54(4):441-448.

Decreased frequency of CD73+CD8+ T cells of HIV-infected patients correlates with immune activation and T cell exhaustion
Tóth I, Le A, Hartjen P, Thomssen A, Matzat V, Lehmann C, Scheurich C, Beisel C, Busch C, Degen O, Lohse A, Eiermann T, Fätkenheuer G, Meyer-Olson D, Bockhorn M, Hauber J, Lunzen J, Schulze Zur Wiesch J
J LEUKOCYTE BIOL. 2013;94(4):551-61.

The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
Volz T, Allweiss L, Ben MBarek M, Warlich M, Lohse A, Pollok J, Alexandrov A, Urban S, Petersen J, Lütgehetmann M, Dandri M
J HEPATOL. 2013;58(5):861-7.

Photodynamic therapy for hilar bile duct cancer: clinical evidence for improved tumoricidal tissue penetration by temoporfin
Wagner A, Kiesslich T, Neureiter D, Friesenbichler P, Puespoek A, Denzer U, Wolkersdörfer G, Emmanuel K, Lohse A, Berr F
Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology. 2013;12(6):1065-73.

Some unusual cystic lesions of the liver
Wehmeyer M, Lohse A, Schramm C
GASTROENTEROLOGY. 2013;145(6):e1-2.

Autoimmune hepatitis 2013 and beyond
Weiler-Normann C, Sebode M, Lohse A
Minerva Gastroenterol Dietol. 2013;59(2):133-41.

Autoimmune hepatitis: a life-long disease.
Weiler-Normann C, Lohse A
J HEPATOL. 2013;58(1):5-7.

Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis.
Weiler-Normann C, Schramm C, Quaas A, Wiegard C, Glaubke C, Pannicke N, Hübener S, Lohse A
J HEPATOL. 2013;58(3):529-534.

Reply to: "Use of TNFα antagonists in refractory AIH: revealing the unforeseen"
Weiler-Normann C, Schramm C, Lohse A
J HEPATOL. 2013;59(1):198-9.

Is fatigue in primary biliary cirrhosis cured by transplantation?
Zenouzi R, Weiler-Normann C, Lohse A
J HEPATOL. 2013;59(3):418-9.

Faldaprevir and deleobuvir for HCV genotype 1 infection
Zeuzem S, Soriano V, Asselah T, Bronowicki J, Lohse A, Müllhaupt B, Schuchmann M, Bourlière M, Buti M, Roberts S, Gane E, Stern J, Vinisko R, Kukolj G, Gallivan J, Böcher W, Mensa F
NEW ENGL J MED. 2013;369(7):630-9.

Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results
Zeuzem S, Asselah T, Angus P, Zarski J, Larrey D, Müllhaupt B, Gane E, Schuchmann M, Lohse A, Pol S, Bronowicki J, Roberts S, Arasteh K, Zoulim F, Heim M, Stern J, Nehmiz G, Kukolj G, Böcher W, Mensa F
ANTIVIR THER. 2013;18(8):1015-9.

Risk factors for development of hemolytic uremic syndrome in a cohort of adult patients with STEC 0104:H4 infection.
Zoufaly A, Cramer J, Vettorazzi E, Sayk F, Bremer J, Koop I, de Weerth A, Schmiedel S, Jordan S, Zimmermann-Fraedrich K, Asselborn N, Nitschke M, Neumann-Grutzeck C, Magnus T, Rüther C, Fellermann K, Stahl R, Wegscheider K, Lohse A
PLOS ONE. 2013;8(3):e59209.

[Intermittent fever under iatrogenic immunosuppression].
Bönstrup M, Schmiedel S, Lohse A
INTERNIST. 2012;53(2):213-217.

Targeting aurora kinases with danusertib (PHA-739358) inhibits growth of liver metastases from gastroenteropancreatic neuroendocrine tumors in an orthotopic xenograft model.
Fraedrich K, Schrader J, Ittrich H, von Amsberg G, Gontarewicz A, Matzat V, Kromminga A, Pace A, Moll J, Bläker M, Lohse A, Hörsch D, Brümmendorf T, Benten D
CLIN CANCER RES. 2012;18(17):4621-4632.

Complications and risk factors in 2731 diagnostic mini-laparoscopies in patients with liver disease.
Frenzel C, Koch J, Lorenzen V, Werner T, Lohse A, Denzer U
LIVER INT. 2012;32(6):970-976.

Acute liver failure following minocycline treatment - a case report and review of the literature.
Kuhn A, Weiler-Normann C, Schramm C, Kluge S, Behne M, Lohse A, Benten D
Z GASTROENTEROL. 2012;50(8):771-775.

Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin.
Larrey D, Lohse A, de Ledinghen V, Trepo C, Gerlach T, Zarski J, Tran A, Mathurin P, Thimme R, Arastéh K, Trautwein C, Cerny A, Dikopoulos N, Schuchmann M, Heim M, Gerken G, Stern J, Wu K, Abdallah N, Girlich B, Scherer J, Berger F, Marquis M, Kukolj G, Böcher W, Steffgen J
J HEPATOL. 2012;57(1):39-46.

Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
Lütgehetmann M, Mancke L, Volz T, Helbig M, Allweiss L, Bornscheuer T, Pollok J, Lohse A, Petersen J, Urban S, Dandri-Petersen M
HEPATOLOGY. 2012;55(3):685-694.

[Autoimmune liver diseases].
Pannicke N, Schramm C, Lohse A
INTERNIST. 2012;53(8):943-946.

FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency.
Peiseler M, Sebode M, Franke B, Wortmann F, Schwinge D, Quaas A, Baron U, Olek S, Wiegard C, Lohse A, Weiler-Normann C, Schramm C, Herkel J
J HEPATOL. 2012;57(1):125-132.

An unusual cause of hypertriglyceridemic acute pancreatitis.
Resheq Y, Rinninger F, Lohse A, Schramm C
AM J GASTROENTEROL. 2012;107(6):957-959.

Gallbladder polyps in primary sclerosing cholangitis: indication for early intervention.
Schramm C, Lohse A
HEPATOLOGY. 2012;56(1):396.

Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence.
Schulze Zur Wiesch J, Ciuffreda D, Lewis-Ximenez L, Kasprowicz V, Nolan B, Streeck H, Aneja J, Reyor L, Allen T, Lohse A, McGovern B, Chung R, Kwok W, Kim A, Lauer G
J EXP MED. 2012;209(1):61-75.

Autoimmunerkrankungen mit Leberbeteiligung
Sebode M, Wiegard C, Lohse A
Gastroenterologie up2date. 2012;08(02):129-141.

The indications for liver biopsy.
Tannapfel A, Dienes H, Lohse A
DTSCH ARZTEBL INT. 2012;109(27-28):477-483.

Treatment adherence - room for improvement, not only in autoimmune hepatitis.
Weiler-Normann C, Lohse A
J HEPATOL. 2012;57(6):1168-1170.

Effectiveness and safety of minilaparoscopy-guided spleen biopsy: a retrospective series of 57 cases.
Werner T, Koch J, Frenzel C, Lohse A, Denzer U
SURG ENDOSC. 2012;26(9):2416-2422.

[Pyogenic liver abscess: a retrospective patient study].
Zenouzi R, Schmiedel S, Lohse A
Z GASTROENTEROL. 2012;50(6):578-584.

The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS).
Benten D, Schulze Zur Wiesch J, Sydow K, Koops A, Buggisch P, Böger R, Gaydos C, Won H, Franco V, Lohse A, Ray S, Balagopal A

Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue.
Boberg K, Chapman R, Hirschfield G, Lohse A, Manns M, Schrumpf E
J HEPATOL. 2011;54(2):374-385.

Lebensmüde ernten ihr Gift neuerdings im Wald ... Suizidversuch mit Knollenblätterpilz
Harlandt O, Wichmann D, de Heer G, Fischer L, Nashan B, Reimer J, Benten D, Lohse A, Kluge S
Medical Tribune. 2011;43(40):7.

Der besondere Fall · Suizidversuch mit Knollenblätterpilz
Harlandt O, Wichmann D, de Heer G, Fischer L, Nashan B, Reimer J, Benten D, Lohse A, Kluge S
Hamb Arztebl. 2011;65(5):34-35.

Rolls Royce for everybody? Diagnosing liver disease by mini-laparoscopy.
Lohse A
J HEPATOL. 2011;54(3):584-585.

Recognizing autoimmune hepatitis: scores help, but no more.
Lohse A
J HEPATOL. 2011;54(2):193-194.

Diagnostic criteria for autoimmune hepatitis.
Lohse A, Wiegard C
BEST PRACT RES CL GA. 2011;25(6):665-671.

Autoimmune hepatitis.
Lohse A, Mieli-Vergani G
J HEPATOL. 2011;55(1):171-182.

Reactivation of autoimmune hepatitis during budesonide monotherapy, and response to standard treatment.
Lohse A, Gil H
J HEPATOL. 2011;54(4):837-839.

Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice.
Lütgehetmann M, Bornscheuer T, Volz T, Allweiss L, Bockmann J, Pollok J, Lohse A, Petersen J, Dandri-Petersen M
GASTROENTEROLOGY. 2011;140(7):1-2, 2074-2083.

Chronic inflammatory IFN-γ signaling suppresses hepatocarcinogenesis in mice by sensitizing hepatocytes for apoptosis.
Lüth S, Schrader J, Zander S, Carambia A, Buchkremer J, Huber S, Reifenberg K, Yamamura K, Schirmacher P, Lohse A, Herkel J
CANCER RES. 2011;71(11):3763-3771.

Case report of aseptic meningitis in a patient with Crohn's disease under infliximab therapy.
Manthey C, Lohse A, Pace A
INFLAMM BOWEL DIS. 2011;17(2):10.

A randomized, double-blind, multicenter phase II AIO trial with gemcitabine plus sorafenib versus gemcitabine plus placebo in patients with chemotherapy-naive advanced or metastatic biliary tract cancer
Moehler M, Schimanski C, Kanzler S, Woerns M, Denzer U, Kolligs F, Ebert M, Distelrath A, Geissler M, Zeuzem S, Lammert F, Lohse A, Dollinger M, Lindig U, Duerr E, Lubomierski N, Zimmermann S, Kabisch M, Schadmann-Fischer S, Galle P
J CLIN ONCOL. 2011;29(15_suppl):4077.

[Lack of data relevant for German transplantation medicine].
Otto G, Lohse A
Z GASTROENTEROL. 2011;49(12):1549-1552.

Role of mycophenolate mofetil in the treatment of autoimmune hepatitis.
Schramm C, Lohse A
J HEPATOL. 2011;55(3):510-511.

Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.
Schulze Zur Wiesch J, Thomssen A, Hartjen P, Toth I, Lehmann C, Meyer-Olson D, Colberg K, Frerk S, Babikir D, Schmiedel S, Degen O, Mauss S, Rockstroh J, Staszewski S, Khaykin P, Strasak A, Lohse A, Fätkenheuer G, Hauber J, van Lunzen J
J VIROL. 2011;85(3):1287-1297.

Real-Life comparison of pegylated-interferon 2a versus 2b combination therapy of chronic hepatitis C virus.
Schulze Zur Wiesch J, Pudelski N, Hoepner L, Supplieth M, Buggisch P, Lohse A, Lüth S
HEPATOLOGY. 2011;53(4):1405-1407.

Forced activation of β-catenin signaling supports the transformation of hTERT-immortalized human fetal hepatocytes.
Wege H, Heim D, Lütgehetmann M, Dierlamm J, Lohse A, Brümmendorf T
MOL CANCER RES. 2011;9(9):1222-1231.

Pregnancy in primary sclerosing cholangitis.
Wellge B, Sterneck M, Teufel A, Rust C, Franke A, Schreiber S, Berg T, Günther R, Kreisel W, Zu Eulenburg C, Braun F, Beuers U, Galle P, Lohse A, Schramm C
GUT. 2011;60(8):1117-1121.

Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infection.
Zeuzem S, Asselah T, Angus P, Zarski J, Larrey D, Müllhaupt B, Gane E, Schuchmann M, Lohse A, Pol S, Bronowicki J, Roberts S, Arasteh K, Zoulim F, Heim M, Stern J, Kukolj G, Nehmiz G, Haefner C, Boecher W
GASTROENTEROLOGY. 2011;141(6):2014-2047.

CCK1 and CCK2 receptors are expressed on pancreatic stellate cells and induce collagen production.
Berna M, Seiz O, Nast J, Benten D, Bläker M, Koch J, Lohse A, Pace A
J BIOL CHEM. 2010;285(50):38905-38914.

Orthotopic Liver Transplantation: Is There a Risk for Listeria monocytogenes Infection?
Ehehalt U, Schmiedel S, Lohse A
Case Report Med. 2010;2010:901894.

Immune-mediated liver injury.
Lohse A, Weiler-Normann C, Tiegs G
J HEPATOL. 2010;52:136-144.

Wissensstand, Präventionsverhalten und Therapieadhärenz von Patienten mit chronischer Hepatitis B in einem großen tertiären Zentrum in Deutschland
Lutgehetmann M, Meyer F, Volz T, Lohse A, Fischer C, Dandri M, Petersen J
Z GASTROENTEROL. 2010;48(9):1126-32.

[Knowledge about HBV, prevention behaviour and treatment adherence of patients with chronic hepatitis B in a large referral centre in Germany].
Lütgehetmann M, Meyer F, Volz T, Lohse A, Fischer C, Dandri-Petersen M, Petersen J
Z GASTROENTEROL. 2010;48(9):1126-1132.

In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice.
Lütgehetmann M, Volz T, Köpke A, Broja T, Tigges E, Lohse A, Fuchs E, Murray J, Petersen J, Dandri-Petersen M
HEPATOLOGY. 2010;52(1):16-24.

Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis.
Manns M, Woynarowski M, Kreisel W, Lurie Y, Rust C, Zuckerman E, Bahr M, Günther R, Hultcrantz R, Spengler U, Lohse A, Szalay F, Färkkilä M, Pröls M, Strassburg C
GASTROENTEROLOGY. 2010;139(4):1198-1206.

[A rare cause of variceal bleeding].
Naderi J, Lohse A, Galle P, Schramm C
Z GASTROENTEROL. 2010;48(10):1215-1218.

Human SepSecS or SLA/LP: selenocysteine formation and autoimmune hepatitis.
Palioura S, Herkel J, Simonovi M, Lohse A, Söll D
BIOL CHEM. 2010;391(7):771-776.

Treatment response in patients with autoimmune hepatitis.
Schramm C, Weiler-Normann C, Wiegard C, Hellweg S, Müller S, Lohse A
HEPATOLOGY. 2010;52(6):2247-2248.

Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry.
Schramm C, Bubenheim M, Adam R, Karam V, Buckels J, O'Grady J, Jamieson N, Pollard S, Neuhaus P, Manns M, Porte R, Castaing D, Paul A, Traynor O, Garden J, Friman S, Ericzon B, Fischer L, Vitko S, Krawczyk M, Metselaar H, Foss A, Kilic M, Rolles K, Burra P, Rogiers X, Lohse A
LIVER TRANSPLANT. 2010;16(4):461-469.

Concurrent autoimmune diseases in patients with autoimmune hepatitis.
Teufel A, Weinmann A, Kahaly G, Centner C, Piendl A, Wörns M, Lohse A, Galle P, Kanzler S
J CLIN GASTROENTEROL. 2010;44(3):208-213.

Immune tolerance: what is unique about the liver.
Tiegs G, Lohse A
J AUTOIMMUN. 2010;34:1-6.

Letzte Aktualisierung aus dem FIS: 26.06.2017 - 00:38 Uhr